Improved insulin sensitivity by anti-TNFα antibody treatment in patients with rheumatic diseases [2]

Annals of the Rheumatic Diseases

Volumn 66, Issue 4, 2007, Pages 558-559

  Huvers, Frank C ^a   Popa, Colin ^a   Netea, Mihai G ^a   Van Den Hoogen, Frank H J ^b   Tack, Cees J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sint Maartenskliniek ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN SENSITIVITY; LETTER; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RHEUMATIC DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34147167977     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.062323     Document Type: Letter

References (9)

1. Wallen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-19.
2. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-19.
3. Svenson KLG, Lundqvist G, Wide L, Hällgren. Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones. Metabolism 1987;36:940-3.
4. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligi GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997;389:610-14.
5. Keijzers GB, de Galan BE, Tack CJ, Smits P. Caffeine can decrease insulin sensitivity in humans. Diabetes care 2002;25:364-9.
6. Tack CJ, Ong MK, Lutterman JA, Smits P. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia 1998;41:569-76.
7. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and grycemic control in patients with NIDDM. Diabetes 1996;45:881-5.
8. Yazdani-Biuki B, Stelzl H, Brezinschek HP, Hermann J, Mueller T, Krippl, et al. Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with anti-TNF-α antibody infliximab. Eur J Clin Invest 2004;34:641-2.
9. Kiortsis DN, Mavridis AK, Vasakos S, Nikas SN, Drosos AA. Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 2005;64:765-6.